Receive the latest mybusiness news
Copyright © 2020 MOMENTUMMEDIA

Vaccine rollout delays could cost businesses over $1.4bn, report finds

Adrian Flores
Adrian Flores
13 April 2021 1 minute readShare
Vaccine rollout delays

The government’s delay in rolling out the COVID-19 vaccine could cost more than $1.4 billion to the Australian economy due to increased chances of further lockouts and restrictions, according to new research modelling.

The McKell Institute said its new report, Counting the cost of Australia’s delayed vaccine rollout, indicated the $1.4 billion estimate is based on even the most optimistic of scenarios.

The federal government’s initial COVID-19 Vaccine Roadmap plan would have reached the earliest possible measure of herd immunity (65 per cent vaccination rate) by August 2021.

However, the McKell Institute said delays have now blown this date out, increasing the chances of further lockouts and restrictions.

It also said that even if Australia instantly picks up it vaccination rollout rate to that of the UK — currently the second-best performer in the world — it would delay herd immunity by 116 days from the Morrison government’s original projection.

Based on this projection, Australia could expect 11.1 days of lockdown in the extra period, costing the economy some $1.368 billion.

By comparison, if Australia were to instantly increase the pace of vaccination to mimic the rate of Germany, the delay would be 353 days with a projected economic cost of $4.164 billion.

The McKell Institute’s executive director, Michael Buckland, said the delays will increase the chance of lockdowns and the economic costs that come with them.

“It’s vital we are clear-sighted about the cost and impact of a government’s action or inaction,” Mr Buckland said.

“Just as it was correct for the government to measure the economic impact of state lockdowns, so, too, should the government embrace the publication of clear information about the economic impact of its vaccination rollout program.

“Australia’s vaccination program has failed to meet its targets and its incomprehensible that we will catch up. Our leaders need to accept the additional risks of delay and act.

“Additional support measures for vulnerable people and businesses must be considered in response to the delay.”

Vaccine rollout delays could cost businesses over $1.4bn, report finds
mybusiness logo
Adrian Flores
Adrian Flores

Adrian Flores is the deputy editor of MyBusiness. Before that, he was the deputy editor for SMSF Adviser as well as features editor for ifa (Independent Financial Adviser), InvestorDaily, Risk Adviser, Fintech Business and Adviser Innovation.

You can email Adrian at [email protected].

Leave a Comment

Latest poll

How satisfied are you with the SME measures in the federal budget?